Wouter Van’t Hof

1.7k total citations
44 papers, 1.3k citations indexed

About

Wouter Van’t Hof is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, Wouter Van’t Hof has authored 44 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 20 papers in Genetics and 13 papers in Immunology. Recurrent topics in Wouter Van’t Hof's work include Mesenchymal stem cell research (19 papers), Hematopoietic Stem Cell Transplantation (10 papers) and Tissue Engineering and Regenerative Medicine (8 papers). Wouter Van’t Hof is often cited by papers focused on Mesenchymal stem cell research (19 papers), Hematopoietic Stem Cell Transplantation (10 papers) and Tissue Engineering and Regenerative Medicine (8 papers). Wouter Van’t Hof collaborates with scholars based in United States, Netherlands and Thailand. Wouter Van’t Hof's co-authors include Robert Deans, Ronald G. Crystal, Gerrit van Meer, Jef Pinxteren, Marilyn D. Resh, Juliana Woda, Anthony E. Ting, Amy Raber, Scott R. Burger and Anant K. Menon and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Cell Biology and Blood.

In The Last Decade

Wouter Van’t Hof

43 papers receiving 1.2k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Wouter Van’t Hof 553 471 259 199 175 44 1.3k
Marta Baiocchi 794 1.4× 396 0.8× 289 1.1× 459 2.3× 164 0.9× 38 1.5k
Shundi Ge 607 1.1× 328 0.7× 371 1.4× 218 1.1× 208 1.2× 26 1.3k
Katsutsugu Umeda 995 1.8× 410 0.9× 486 1.9× 232 1.2× 193 1.1× 108 1.8k
Anthony S. Perry 621 1.1× 610 1.3× 385 1.5× 223 1.1× 194 1.1× 14 1.4k
Hans-Jörg Bühring 577 1.0× 432 0.9× 271 1.0× 212 1.1× 284 1.6× 16 1.3k
Erin A. Kimbrel 888 1.6× 367 0.8× 328 1.3× 181 0.9× 235 1.3× 25 1.7k
César Trigueros 652 1.2× 647 1.4× 340 1.3× 276 1.4× 551 3.1× 34 1.8k
Alexis S. Bailey 875 1.6× 374 0.8× 321 1.2× 339 1.7× 240 1.4× 17 1.6k
Elena Tenedini 933 1.7× 500 1.1× 183 0.7× 290 1.5× 240 1.4× 53 1.7k
Shi‐Jiang Lu 1.4k 2.5× 330 0.7× 309 1.2× 111 0.6× 217 1.2× 40 2.0k

Countries citing papers authored by Wouter Van’t Hof

Since Specialization
Citations

This map shows the geographic impact of Wouter Van’t Hof's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wouter Van’t Hof with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wouter Van’t Hof more than expected).

Fields of papers citing papers by Wouter Van’t Hof

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wouter Van’t Hof. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wouter Van’t Hof. The network helps show where Wouter Van’t Hof may publish in the future.

Co-authorship network of co-authors of Wouter Van’t Hof

This figure shows the co-authorship network connecting the top 25 collaborators of Wouter Van’t Hof. A scholar is included among the top collaborators of Wouter Van’t Hof based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wouter Van’t Hof. Wouter Van’t Hof is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Broxmeyer, Hal E., Larry L. Luchsinger, Rona Singer Weinberg, et al.. (2023). Insights into highly engraftable hematopoietic cells from 27-year cryopreserved umbilical cord blood. Cell Reports Medicine. 4(11). 101259–101259. 5 indexed citations
2.
Dumont-Lagacé, Maude, et al.. (2022). UM171 Expansion of Cord Blood Improves Donor Availability and HLA Matching For All Patients, Including Minorities. Transplantation and Cellular Therapy. 28(7). 410.e1–410.e5. 16 indexed citations
3.
Do, Jeong‐su, Daniel B. Zwick, Jonathan Kenyon, et al.. (2021). Mesenchymal stromal cell mitochondrial transfer to human induced T-regulatory cells mediates FOXP3 stability. Scientific Reports. 11(1). 10676–10676. 27 indexed citations
4.
Ropa, James, Scott Cooper, Maegan L. Capitano, Wouter Van’t Hof, & Hal E. Broxmeyer. (2020). Human Hematopoietic Stem, Progenitor, and Immune Cells Respond Ex Vivo to SARS-CoV-2 Spike Protein. Stem Cell Reviews and Reports. 17(1). 253–265. 59 indexed citations
6.
Gargesha, Madhusudhana, et al.. (2015). Automatic Stem Cell Detection in Microscopic Whole Mouse Cryo-Imaging. IEEE Transactions on Medical Imaging. 35(3). 819–829. 17 indexed citations
7.
Maziarz, Richard T., Timothy Devos, Carlos Bachier, et al.. (2014). Single and Multiple Dose MultiStem (Multipotent Adult Progenitor Cell) Therapy Prophylaxis of Acute Graft-versus-Host Disease in Myeloablative Allogeneic Hematopoietic Cell Transplantation: A Phase 1 Trial. Biology of Blood and Marrow Transplantation. 21(4). 720–728. 44 indexed citations
8.
Vaes, Bart, et al.. (2014). Culturing Protocols for Human Multipotent Adult Stem Cells. Methods in molecular biology. 1235. 49–58. 5 indexed citations
9.
Burrows, Gregory G., Richard T. Maziarz, Nicholas Lehman, et al.. (2013). Human multipotent adult progenitor cells transcriptionally regulate fucosyltransferase VII. Cytotherapy. 16(4). 566–575. 5 indexed citations
10.
Lehman, Nicholas, Rochelle Cutrone, Amy Raber, et al.. (2012). Development of a surrogate angiogenic potency assay for clinical-grade stem cell production. Cytotherapy. 14(8). 994–1004. 49 indexed citations
11.
Vaes, Bart, Wouter Van’t Hof, Robert Deans, & Jef Pinxteren. (2012). Application of MultiStem® Allogeneic Cells for Immunomodulatory Therapy: Clinical Progress and Pre-Clinical Challenges in Prophylaxis for Graft Versus Host Disease. Frontiers in Immunology. 3. 345–345. 55 indexed citations
12.
Auletta, Jeffery J., Kenneth R. Cooke, Luis A. Solchaga, Robert Deans, & Wouter Van’t Hof. (2009). Regenerative Stromal Cell Therapy in Allogeneic Hematopoietic Stem Cell Transplantation: Current Impact and Future Directions. Biology of Blood and Marrow Transplantation. 16(7). 891–906. 33 indexed citations
13.
Kovacsovics‐Bankowski, Magdalena, Philip R. Streeter, Mark R. Frey, et al.. (2008). Clinical scale expanded adult pluripotent stem cells prevent graft-versus-host disease. Cellular Immunology. 255(1-2). 55–60. 41 indexed citations
14.
Kovacsovics‐Bankowski, Magdalena, et al.. (2008). Pre-clinical safety testing supporting clinical use of allogeneic multipotent adult progenitor cells. Cytotherapy. 10(7). 730–742. 31 indexed citations
15.
Hof, Wouter Van’t, Niladri Mal, Yan Huang, et al.. (2007). Direct delivery of syngeneic and allogeneic large-scale expanded multipotent adult progenitor cells improves cardiac function after myocardial infarct. Cytotherapy. 9(5). 477–487. 43 indexed citations
16.
Ting, Anthony E., Robert W. Mays, Mark R. Frey, et al.. (2007). Therapeutic pathways of adult stem cell repair. Critical Reviews in Oncology/Hematology. 65(1). 81–93. 34 indexed citations
17.
Hof, Wouter Van’t, et al.. (2003). Analysis of Myristoylated and Palmitoylated Src Family Proteins. Humana Press eBooks. 84. 261–266. 4 indexed citations
19.
Hof, Wouter Van’t & Marilyn D. Resh. (2000). Targeting proteins to plasma membrane and membrane microdomains by N-terminal myristoylation and palmitoylation. Methods in enzymology on CD-ROM/Methods in enzymology. 327. 317–330. 23 indexed citations
20.
Hof, Wouter Van’t, Enrique Rodríguez-Boulan, & Anant K. Menon. (1995). Nonpolarized Distribution of Glycosylphosphatidylinositols in the Plasma Membrane of Polarized Madin-Darby Canine Kidney Cells. Journal of Biological Chemistry. 270(41). 24150–24155. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026